nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2D6—Alzheimer's disease	0.296	1	CbGaD
Bicalutamide—CYP2D6—Rivastigmine—Alzheimer's disease	0.083	0.18	CbGbCtD
Bicalutamide—CYP2C19—Memantine—Alzheimer's disease	0.0757	0.164	CbGbCtD
Bicalutamide—CYP2C9—Donepezil—Alzheimer's disease	0.0726	0.157	CbGbCtD
Bicalutamide—CYP2D6—Donepezil—Alzheimer's disease	0.0664	0.144	CbGbCtD
Bicalutamide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0528	0.114	CbGbCtD
Bicalutamide—CYP2D6—Galantamine—Alzheimer's disease	0.0428	0.0925	CbGbCtD
Bicalutamide—CYP3A4—Donepezil—Alzheimer's disease	0.0422	0.0913	CbGbCtD
Bicalutamide—CYP3A4—Galantamine—Alzheimer's disease	0.0272	0.0588	CbGbCtD
Bicalutamide—Enzalutamide—CYP2D6—Alzheimer's disease	0.00121	1	CrCbGaD
Bicalutamide—Haemorrhage—Donepezil—Alzheimer's disease	0.000329	0.00151	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000328	0.0015	CcSEcCtD
Bicalutamide—Pneumonia—Rivastigmine—Alzheimer's disease	0.000327	0.0015	CcSEcCtD
Bicalutamide—Pharyngitis—Donepezil—Alzheimer's disease	0.000326	0.0015	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000326	0.00149	CcSEcCtD
Bicalutamide—Myocardial infarction—Memantine—Alzheimer's disease	0.000326	0.00149	CcSEcCtD
Bicalutamide—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000325	0.00149	CcSEcCtD
Bicalutamide—Loss of consciousness—Galantamine—Alzheimer's disease	0.000325	0.00149	CcSEcCtD
Bicalutamide—Depression—Rivastigmine—Alzheimer's disease	0.000325	0.00149	CcSEcCtD
Bicalutamide—Oedema peripheral—Donepezil—Alzheimer's disease	0.000324	0.00149	CcSEcCtD
Bicalutamide—Urinary tract infection—Memantine—Alzheimer's disease	0.000323	0.00148	CcSEcCtD
Bicalutamide—Conjunctivitis—Memantine—Alzheimer's disease	0.000323	0.00148	CcSEcCtD
Bicalutamide—Urethral disorder—Donepezil—Alzheimer's disease	0.000322	0.00148	CcSEcCtD
Bicalutamide—Cough—Galantamine—Alzheimer's disease	0.000322	0.00148	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000321	0.00147	CcSEcCtD
Bicalutamide—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000319	0.00146	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000319	0.00146	CcSEcCtD
Bicalutamide—Hypertension—Galantamine—Alzheimer's disease	0.000319	0.00146	CcSEcCtD
Bicalutamide—Haematuria—Memantine—Alzheimer's disease	0.000317	0.00145	CcSEcCtD
Bicalutamide—Visual impairment—Donepezil—Alzheimer's disease	0.000317	0.00145	CcSEcCtD
Bicalutamide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000316	0.00145	CcSEcCtD
Bicalutamide—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000316	0.00145	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000315	0.00144	CcSEcCtD
Bicalutamide—Chest pain—Galantamine—Alzheimer's disease	0.000315	0.00144	CcSEcCtD
Bicalutamide—Myalgia—Galantamine—Alzheimer's disease	0.000315	0.00144	CcSEcCtD
Bicalutamide—Epistaxis—Memantine—Alzheimer's disease	0.000314	0.00144	CcSEcCtD
Bicalutamide—Anxiety—Galantamine—Alzheimer's disease	0.000313	0.00144	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000312	0.00143	CcSEcCtD
Bicalutamide—Sinusitis—Memantine—Alzheimer's disease	0.000312	0.00143	CcSEcCtD
Bicalutamide—Sweating—Rivastigmine—Alzheimer's disease	0.000312	0.00143	CcSEcCtD
Bicalutamide—Haematuria—Rivastigmine—Alzheimer's disease	0.00031	0.00142	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000308	0.00141	CcSEcCtD
Bicalutamide—Dry mouth—Galantamine—Alzheimer's disease	0.000308	0.00141	CcSEcCtD
Bicalutamide—Epistaxis—Rivastigmine—Alzheimer's disease	0.000307	0.00141	CcSEcCtD
Bicalutamide—Sinusitis—Rivastigmine—Alzheimer's disease	0.000305	0.0014	CcSEcCtD
Bicalutamide—Confusional state—Galantamine—Alzheimer's disease	0.000304	0.00139	CcSEcCtD
Bicalutamide—Bradycardia—Memantine—Alzheimer's disease	0.000304	0.00139	CcSEcCtD
Bicalutamide—Haemoglobin—Memantine—Alzheimer's disease	0.0003	0.00138	CcSEcCtD
Bicalutamide—Rhinitis—Memantine—Alzheimer's disease	0.000299	0.00137	CcSEcCtD
Bicalutamide—Haemorrhage—Memantine—Alzheimer's disease	0.000299	0.00137	CcSEcCtD
Bicalutamide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000297	0.00136	CcSEcCtD
Bicalutamide—Shock—Galantamine—Alzheimer's disease	0.000297	0.00136	CcSEcCtD
Bicalutamide—Pharyngitis—Memantine—Alzheimer's disease	0.000296	0.00136	CcSEcCtD
Bicalutamide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000296	0.00136	CcSEcCtD
Bicalutamide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000295	0.00135	CcSEcCtD
Bicalutamide—Chills—Donepezil—Alzheimer's disease	0.000295	0.00135	CcSEcCtD
Bicalutamide—Urinary tract disorder—Memantine—Alzheimer's disease	0.000295	0.00135	CcSEcCtD
Bicalutamide—Oedema peripheral—Memantine—Alzheimer's disease	0.000294	0.00135	CcSEcCtD
Bicalutamide—Arrhythmia—Donepezil—Alzheimer's disease	0.000294	0.00135	CcSEcCtD
Bicalutamide—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000294	0.00135	CcSEcCtD
Bicalutamide—Rhinitis—Rivastigmine—Alzheimer's disease	0.000293	0.00134	CcSEcCtD
Bicalutamide—Skin disorder—Galantamine—Alzheimer's disease	0.000293	0.00134	CcSEcCtD
Bicalutamide—Urethral disorder—Memantine—Alzheimer's disease	0.000293	0.00134	CcSEcCtD
Bicalutamide—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000292	0.00134	CcSEcCtD
Bicalutamide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000292	0.00134	CcSEcCtD
Bicalutamide—Alopecia—Donepezil—Alzheimer's disease	0.000291	0.00133	CcSEcCtD
Bicalutamide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00029	0.00133	CcSEcCtD
Bicalutamide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000289	0.00132	CcSEcCtD
Bicalutamide—Mental disorder—Donepezil—Alzheimer's disease	0.000288	0.00132	CcSEcCtD
Bicalutamide—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000288	0.00132	CcSEcCtD
Bicalutamide—Visual impairment—Memantine—Alzheimer's disease	0.000288	0.00132	CcSEcCtD
Bicalutamide—Anorexia—Galantamine—Alzheimer's disease	0.000287	0.00132	CcSEcCtD
Bicalutamide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000286	0.00131	CcSEcCtD
Bicalutamide—Malnutrition—Donepezil—Alzheimer's disease	0.000286	0.00131	CcSEcCtD
Bicalutamide—Flatulence—Donepezil—Alzheimer's disease	0.000282	0.00129	CcSEcCtD
Bicalutamide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000282	0.00129	CcSEcCtD
Bicalutamide—Tension—Donepezil—Alzheimer's disease	0.000281	0.00129	CcSEcCtD
Bicalutamide—Nervousness—Donepezil—Alzheimer's disease	0.000278	0.00127	CcSEcCtD
Bicalutamide—Cardiac disorder—Memantine—Alzheimer's disease	0.000277	0.00127	CcSEcCtD
Bicalutamide—Back pain—Donepezil—Alzheimer's disease	0.000277	0.00127	CcSEcCtD
Bicalutamide—Muscle spasms—Donepezil—Alzheimer's disease	0.000275	0.00126	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000275	0.00126	CcSEcCtD
Bicalutamide—Insomnia—Galantamine—Alzheimer's disease	0.000273	0.00125	CcSEcCtD
Bicalutamide—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000271	0.00124	CcSEcCtD
Bicalutamide—Angiopathy—Memantine—Alzheimer's disease	0.000271	0.00124	CcSEcCtD
Bicalutamide—Paraesthesia—Galantamine—Alzheimer's disease	0.000271	0.00124	CcSEcCtD
Bicalutamide—Immune system disorder—Memantine—Alzheimer's disease	0.00027	0.00124	CcSEcCtD
Bicalutamide—Mediastinal disorder—Memantine—Alzheimer's disease	0.000269	0.00123	CcSEcCtD
Bicalutamide—Somnolence—Galantamine—Alzheimer's disease	0.000268	0.00123	CcSEcCtD
Bicalutamide—Chills—Memantine—Alzheimer's disease	0.000268	0.00123	CcSEcCtD
Bicalutamide—Arrhythmia—Memantine—Alzheimer's disease	0.000267	0.00122	CcSEcCtD
Bicalutamide—Dyspepsia—Galantamine—Alzheimer's disease	0.000265	0.00122	CcSEcCtD
Bicalutamide—Angiopathy—Rivastigmine—Alzheimer's disease	0.000265	0.00121	CcSEcCtD
Bicalutamide—Anaemia—Donepezil—Alzheimer's disease	0.000265	0.00121	CcSEcCtD
Bicalutamide—Alopecia—Memantine—Alzheimer's disease	0.000264	0.00121	CcSEcCtD
Bicalutamide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000263	0.00121	CcSEcCtD
Bicalutamide—Chills—Rivastigmine—Alzheimer's disease	0.000262	0.0012	CcSEcCtD
Bicalutamide—Decreased appetite—Galantamine—Alzheimer's disease	0.000262	0.0012	CcSEcCtD
Bicalutamide—Mental disorder—Memantine—Alzheimer's disease	0.000262	0.0012	CcSEcCtD
Bicalutamide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000261	0.0012	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00026	0.00119	CcSEcCtD
Bicalutamide—Malnutrition—Memantine—Alzheimer's disease	0.00026	0.00119	CcSEcCtD
Bicalutamide—Fatigue—Galantamine—Alzheimer's disease	0.00026	0.00119	CcSEcCtD
Bicalutamide—Alopecia—Rivastigmine—Alzheimer's disease	0.000258	0.00118	CcSEcCtD
Bicalutamide—Constipation—Galantamine—Alzheimer's disease	0.000258	0.00118	CcSEcCtD
Bicalutamide—Syncope—Donepezil—Alzheimer's disease	0.000257	0.00118	CcSEcCtD
Bicalutamide—Flatulence—Memantine—Alzheimer's disease	0.000256	0.00117	CcSEcCtD
Bicalutamide—Mental disorder—Rivastigmine—Alzheimer's disease	0.000256	0.00117	CcSEcCtD
Bicalutamide—Tension—Memantine—Alzheimer's disease	0.000255	0.00117	CcSEcCtD
Bicalutamide—Malnutrition—Rivastigmine—Alzheimer's disease	0.000254	0.00117	CcSEcCtD
Bicalutamide—Nervousness—Memantine—Alzheimer's disease	0.000253	0.00116	CcSEcCtD
Bicalutamide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000252	0.00115	CcSEcCtD
Bicalutamide—Back pain—Memantine—Alzheimer's disease	0.000251	0.00115	CcSEcCtD
Bicalutamide—Flatulence—Rivastigmine—Alzheimer's disease	0.000251	0.00115	CcSEcCtD
Bicalutamide—Cough—Donepezil—Alzheimer's disease	0.00025	0.00115	CcSEcCtD
Bicalutamide—Tension—Rivastigmine—Alzheimer's disease	0.00025	0.00114	CcSEcCtD
Bicalutamide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000249	0.00114	CcSEcCtD
Bicalutamide—Hypertension—Donepezil—Alzheimer's disease	0.000247	0.00113	CcSEcCtD
Bicalutamide—Nervousness—Rivastigmine—Alzheimer's disease	0.000247	0.00113	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000247	0.00113	CcSEcCtD
Bicalutamide—Back pain—Rivastigmine—Alzheimer's disease	0.000246	0.00113	CcSEcCtD
Bicalutamide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000245	0.00112	CcSEcCtD
Bicalutamide—Myalgia—Donepezil—Alzheimer's disease	0.000244	0.00112	CcSEcCtD
Bicalutamide—Chest pain—Donepezil—Alzheimer's disease	0.000244	0.00112	CcSEcCtD
Bicalutamide—Anxiety—Donepezil—Alzheimer's disease	0.000243	0.00111	CcSEcCtD
Bicalutamide—Anaemia—Memantine—Alzheimer's disease	0.00024	0.0011	CcSEcCtD
Bicalutamide—Dry mouth—Donepezil—Alzheimer's disease	0.000238	0.00109	CcSEcCtD
Bicalutamide—Abdominal pain—Galantamine—Alzheimer's disease	0.000238	0.00109	CcSEcCtD
Bicalutamide—Body temperature increased—Galantamine—Alzheimer's disease	0.000238	0.00109	CcSEcCtD
Bicalutamide—Confusional state—Donepezil—Alzheimer's disease	0.000236	0.00108	CcSEcCtD
Bicalutamide—Anaemia—Rivastigmine—Alzheimer's disease	0.000235	0.00108	CcSEcCtD
Bicalutamide—Oedema—Donepezil—Alzheimer's disease	0.000234	0.00107	CcSEcCtD
Bicalutamide—Syncope—Memantine—Alzheimer's disease	0.000233	0.00107	CcSEcCtD
Bicalutamide—Infection—Donepezil—Alzheimer's disease	0.000232	0.00106	CcSEcCtD
Bicalutamide—Shock—Donepezil—Alzheimer's disease	0.00023	0.00105	CcSEcCtD
Bicalutamide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000229	0.00105	CcSEcCtD
Bicalutamide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000229	0.00105	CcSEcCtD
Bicalutamide—Loss of consciousness—Memantine—Alzheimer's disease	0.000229	0.00105	CcSEcCtD
Bicalutamide—Syncope—Rivastigmine—Alzheimer's disease	0.000228	0.00105	CcSEcCtD
Bicalutamide—Cough—Memantine—Alzheimer's disease	0.000227	0.00104	CcSEcCtD
Bicalutamide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000226	0.00104	CcSEcCtD
Bicalutamide—Hypertension—Memantine—Alzheimer's disease	0.000224	0.00103	CcSEcCtD
Bicalutamide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000224	0.00102	CcSEcCtD
Bicalutamide—Anorexia—Donepezil—Alzheimer's disease	0.000223	0.00102	CcSEcCtD
Bicalutamide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000222	0.00102	CcSEcCtD
Bicalutamide—Cough—Rivastigmine—Alzheimer's disease	0.000222	0.00102	CcSEcCtD
Bicalutamide—Chest pain—Memantine—Alzheimer's disease	0.000221	0.00101	CcSEcCtD
Bicalutamide—Myalgia—Memantine—Alzheimer's disease	0.000221	0.00101	CcSEcCtD
Bicalutamide—Anxiety—Memantine—Alzheimer's disease	0.000221	0.00101	CcSEcCtD
Bicalutamide—Hypertension—Rivastigmine—Alzheimer's disease	0.00022	0.00101	CcSEcCtD
Bicalutamide—Myalgia—Rivastigmine—Alzheimer's disease	0.000217	0.000992	CcSEcCtD
Bicalutamide—Chest pain—Rivastigmine—Alzheimer's disease	0.000217	0.000992	CcSEcCtD
Bicalutamide—Dry mouth—Memantine—Alzheimer's disease	0.000216	0.000992	CcSEcCtD
Bicalutamide—Asthenia—Galantamine—Alzheimer's disease	0.000216	0.000992	CcSEcCtD
Bicalutamide—Anxiety—Rivastigmine—Alzheimer's disease	0.000216	0.000989	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000215	0.000986	CcSEcCtD
Bicalutamide—Confusional state—Memantine—Alzheimer's disease	0.000214	0.000981	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000213	0.000976	CcSEcCtD
Bicalutamide—Oedema—Memantine—Alzheimer's disease	0.000212	0.000972	CcSEcCtD
Bicalutamide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000212	0.000971	CcSEcCtD
Bicalutamide—Insomnia—Donepezil—Alzheimer's disease	0.000211	0.000969	CcSEcCtD
Bicalutamide—Infection—Memantine—Alzheimer's disease	0.000211	0.000966	CcSEcCtD
Bicalutamide—Paraesthesia—Donepezil—Alzheimer's disease	0.00021	0.000962	CcSEcCtD
Bicalutamide—Confusional state—Rivastigmine—Alzheimer's disease	0.000209	0.000959	CcSEcCtD
Bicalutamide—Shock—Memantine—Alzheimer's disease	0.000209	0.000957	CcSEcCtD
Bicalutamide—Dyspnoea—Donepezil—Alzheimer's disease	0.000208	0.000955	CcSEcCtD
Bicalutamide—Nervous system disorder—Memantine—Alzheimer's disease	0.000208	0.000954	CcSEcCtD
Bicalutamide—Somnolence—Donepezil—Alzheimer's disease	0.000208	0.000952	CcSEcCtD
Bicalutamide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000208	0.000952	CcSEcCtD
Bicalutamide—Oedema—Rivastigmine—Alzheimer's disease	0.000208	0.000951	CcSEcCtD
Bicalutamide—Diarrhoea—Galantamine—Alzheimer's disease	0.000206	0.000946	CcSEcCtD
Bicalutamide—Infection—Rivastigmine—Alzheimer's disease	0.000206	0.000945	CcSEcCtD
Bicalutamide—Skin disorder—Memantine—Alzheimer's disease	0.000206	0.000945	CcSEcCtD
Bicalutamide—Dyspepsia—Donepezil—Alzheimer's disease	0.000206	0.000943	CcSEcCtD
Bicalutamide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000205	0.00094	CcSEcCtD
Bicalutamide—Shock—Rivastigmine—Alzheimer's disease	0.000204	0.000936	CcSEcCtD
Bicalutamide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000204	0.000933	CcSEcCtD
Bicalutamide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000203	0.000931	CcSEcCtD
Bicalutamide—Decreased appetite—Donepezil—Alzheimer's disease	0.000203	0.000931	CcSEcCtD
Bicalutamide—Anorexia—Memantine—Alzheimer's disease	0.000202	0.000927	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000202	0.000925	CcSEcCtD
Bicalutamide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000202	0.000924	CcSEcCtD
Bicalutamide—Fatigue—Donepezil—Alzheimer's disease	0.000201	0.000923	CcSEcCtD
Bicalutamide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000201	0.00092	CcSEcCtD
Bicalutamide—Pain—Donepezil—Alzheimer's disease	0.0002	0.000916	CcSEcCtD
Bicalutamide—Constipation—Donepezil—Alzheimer's disease	0.0002	0.000916	CcSEcCtD
Bicalutamide—Dizziness—Galantamine—Alzheimer's disease	0.000199	0.000914	CcSEcCtD
Bicalutamide—Anorexia—Rivastigmine—Alzheimer's disease	0.000198	0.000907	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000193	0.000886	CcSEcCtD
Bicalutamide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000193	0.000883	CcSEcCtD
Bicalutamide—Insomnia—Memantine—Alzheimer's disease	0.000192	0.00088	CcSEcCtD
Bicalutamide—Vomiting—Galantamine—Alzheimer's disease	0.000192	0.000879	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000191	0.000876	CcSEcCtD
Bicalutamide—Paraesthesia—Memantine—Alzheimer's disease	0.000191	0.000873	CcSEcCtD
Bicalutamide—Rash—Galantamine—Alzheimer's disease	0.00019	0.000871	CcSEcCtD
Bicalutamide—Dermatitis—Galantamine—Alzheimer's disease	0.00019	0.000871	CcSEcCtD
Bicalutamide—Dyspnoea—Memantine—Alzheimer's disease	0.000189	0.000867	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000189	0.000867	CcSEcCtD
Bicalutamide—Headache—Galantamine—Alzheimer's disease	0.000189	0.000866	CcSEcCtD
Bicalutamide—Somnolence—Memantine—Alzheimer's disease	0.000189	0.000864	CcSEcCtD
Bicalutamide—Insomnia—Rivastigmine—Alzheimer's disease	0.000188	0.00086	CcSEcCtD
Bicalutamide—Dyspepsia—Memantine—Alzheimer's disease	0.000187	0.000856	CcSEcCtD
Bicalutamide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000186	0.000854	CcSEcCtD
Bicalutamide—Urticaria—Donepezil—Alzheimer's disease	0.000186	0.000851	CcSEcCtD
Bicalutamide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000185	0.000848	CcSEcCtD
Bicalutamide—Body temperature increased—Donepezil—Alzheimer's disease	0.000185	0.000847	CcSEcCtD
Bicalutamide—Abdominal pain—Donepezil—Alzheimer's disease	0.000185	0.000847	CcSEcCtD
Bicalutamide—Somnolence—Rivastigmine—Alzheimer's disease	0.000185	0.000846	CcSEcCtD
Bicalutamide—Decreased appetite—Memantine—Alzheimer's disease	0.000184	0.000845	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000183	0.00084	CcSEcCtD
Bicalutamide—Fatigue—Memantine—Alzheimer's disease	0.000183	0.000838	CcSEcCtD
Bicalutamide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000183	0.000837	CcSEcCtD
Bicalutamide—Constipation—Memantine—Alzheimer's disease	0.000181	0.000832	CcSEcCtD
Bicalutamide—Pain—Memantine—Alzheimer's disease	0.000181	0.000832	CcSEcCtD
Bicalutamide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00018	0.000827	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000179	0.000821	CcSEcCtD
Bicalutamide—Nausea—Galantamine—Alzheimer's disease	0.000179	0.000821	CcSEcCtD
Bicalutamide—Fatigue—Rivastigmine—Alzheimer's disease	0.000179	0.00082	CcSEcCtD
Bicalutamide—Pain—Rivastigmine—Alzheimer's disease	0.000178	0.000814	CcSEcCtD
Bicalutamide—Constipation—Rivastigmine—Alzheimer's disease	0.000178	0.000814	CcSEcCtD
Bicalutamide—Feeling abnormal—Memantine—Alzheimer's disease	0.000175	0.000801	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000174	0.000795	CcSEcCtD
Bicalutamide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000172	0.000789	CcSEcCtD
Bicalutamide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000171	0.000784	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00017	0.000778	CcSEcCtD
Bicalutamide—Urticaria—Memantine—Alzheimer's disease	0.000169	0.000773	CcSEcCtD
Bicalutamide—Body temperature increased—Memantine—Alzheimer's disease	0.000168	0.000769	CcSEcCtD
Bicalutamide—Abdominal pain—Memantine—Alzheimer's disease	0.000168	0.000769	CcSEcCtD
Bicalutamide—Asthenia—Donepezil—Alzheimer's disease	0.000168	0.000768	CcSEcCtD
Bicalutamide—Pruritus—Donepezil—Alzheimer's disease	0.000165	0.000758	CcSEcCtD
Bicalutamide—Urticaria—Rivastigmine—Alzheimer's disease	0.000165	0.000756	CcSEcCtD
Bicalutamide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000164	0.000752	CcSEcCtD
Bicalutamide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000164	0.000752	CcSEcCtD
Bicalutamide—Diarrhoea—Donepezil—Alzheimer's disease	0.00016	0.000733	CcSEcCtD
Bicalutamide—Hypersensitivity—Memantine—Alzheimer's disease	0.000156	0.000716	CcSEcCtD
Bicalutamide—Dizziness—Donepezil—Alzheimer's disease	0.000155	0.000708	CcSEcCtD
Bicalutamide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000153	0.000701	CcSEcCtD
Bicalutamide—Asthenia—Memantine—Alzheimer's disease	0.000152	0.000698	CcSEcCtD
Bicalutamide—Pruritus—Memantine—Alzheimer's disease	0.00015	0.000688	CcSEcCtD
Bicalutamide—Asthenia—Rivastigmine—Alzheimer's disease	0.000149	0.000683	CcSEcCtD
Bicalutamide—Vomiting—Donepezil—Alzheimer's disease	0.000149	0.000681	CcSEcCtD
Bicalutamide—Rash—Donepezil—Alzheimer's disease	0.000147	0.000675	CcSEcCtD
Bicalutamide—Dermatitis—Donepezil—Alzheimer's disease	0.000147	0.000675	CcSEcCtD
Bicalutamide—Pruritus—Rivastigmine—Alzheimer's disease	0.000147	0.000673	CcSEcCtD
Bicalutamide—Headache—Donepezil—Alzheimer's disease	0.000146	0.000671	CcSEcCtD
Bicalutamide—Diarrhoea—Memantine—Alzheimer's disease	0.000145	0.000665	CcSEcCtD
Bicalutamide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000142	0.000651	CcSEcCtD
Bicalutamide—Dizziness—Memantine—Alzheimer's disease	0.00014	0.000643	CcSEcCtD
Bicalutamide—Nausea—Donepezil—Alzheimer's disease	0.000139	0.000636	CcSEcCtD
Bicalutamide—Dizziness—Rivastigmine—Alzheimer's disease	0.000137	0.000629	CcSEcCtD
Bicalutamide—Vomiting—Memantine—Alzheimer's disease	0.000135	0.000618	CcSEcCtD
Bicalutamide—Rash—Memantine—Alzheimer's disease	0.000134	0.000613	CcSEcCtD
Bicalutamide—Dermatitis—Memantine—Alzheimer's disease	0.000134	0.000613	CcSEcCtD
Bicalutamide—Headache—Memantine—Alzheimer's disease	0.000133	0.000609	CcSEcCtD
Bicalutamide—Vomiting—Rivastigmine—Alzheimer's disease	0.000132	0.000605	CcSEcCtD
Bicalutamide—Rash—Rivastigmine—Alzheimer's disease	0.000131	0.0006	CcSEcCtD
Bicalutamide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000131	0.000599	CcSEcCtD
Bicalutamide—Headache—Rivastigmine—Alzheimer's disease	0.00013	0.000596	CcSEcCtD
Bicalutamide—Nausea—Memantine—Alzheimer's disease	0.000126	0.000578	CcSEcCtD
Bicalutamide—Nausea—Rivastigmine—Alzheimer's disease	0.000123	0.000565	CcSEcCtD
Bicalutamide—CYP2C19—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	8.78e-05	0.00391	CbGpPWpGaD
Bicalutamide—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	8.76e-05	0.0039	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	8.75e-05	0.0039	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	8.68e-05	0.00387	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	8.57e-05	0.00382	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	8.5e-05	0.00379	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	8.28e-05	0.00369	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	8.21e-05	0.00366	CbGpPWpGaD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	8.16e-05	0.00364	CbGpPWpGaD
Bicalutamide—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	8.07e-05	0.0036	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	8.05e-05	0.00359	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	8.04e-05	0.00358	CbGpPWpGaD
Bicalutamide—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	7.92e-05	0.00353	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	7.72e-05	0.00344	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	7.68e-05	0.00342	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.55e-05	0.00337	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.49e-05	0.00334	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	7.47e-05	0.00333	CbGpPWpGaD
Bicalutamide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	7.38e-05	0.00329	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	7.34e-05	0.00327	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	7.14e-05	0.00318	CbGpPWpGaD
Bicalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	7.09e-05	0.00316	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	6.84e-05	0.00305	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	6.8e-05	0.00303	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	6.52e-05	0.0029	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PHF1—Alzheimer's disease	6.47e-05	0.00289	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	6.36e-05	0.00284	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	6.19e-05	0.00276	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	5.97e-05	0.00266	CbGpPWpGaD
Bicalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	5.9e-05	0.00263	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	5.8e-05	0.00259	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—MAOB—Alzheimer's disease	5.76e-05	0.00256	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	5.72e-05	0.00255	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	5.57e-05	0.00248	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	5.55e-05	0.00247	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	5.43e-05	0.00242	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	5.29e-05	0.00236	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	5.25e-05	0.00234	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	5.13e-05	0.00229	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	5.06e-05	0.00226	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	4.94e-05	0.0022	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	4.84e-05	0.00216	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	4.68e-05	0.00208	CbGpPWpGaD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	4.67e-05	0.00208	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	4.62e-05	0.00206	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	4.61e-05	0.00205	CbGpPWpGaD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	4.49e-05	0.002	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.44e-05	0.00198	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	4.36e-05	0.00194	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	4.28e-05	0.00191	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.22e-05	0.00188	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—TFAM—Alzheimer's disease	4.17e-05	0.00186	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	4.12e-05	0.00184	CbGpPWpGaD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	4.1e-05	0.00183	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	4.03e-05	0.00179	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	4.02e-05	0.00179	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	4.01e-05	0.00179	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	4.01e-05	0.00179	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	3.98e-05	0.00177	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	3.9e-05	0.00174	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.88e-05	0.00173	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.85e-05	0.00171	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.7e-05	0.00165	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.68e-05	0.00164	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	3.68e-05	0.00164	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.66e-05	0.00163	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	3.5e-05	0.00156	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.46e-05	0.00154	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.42e-05	0.00152	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.41e-05	0.00152	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	3.41e-05	0.00152	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.38e-05	0.00151	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.14e-05	0.0014	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.92e-05	0.0013	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.9e-05	0.00129	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.66e-05	0.00119	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	2.64e-05	0.00118	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.62e-05	0.00117	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.57e-05	0.00115	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	2.55e-05	0.00114	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.54e-05	0.00113	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—EIF2S1—Alzheimer's disease	2.51e-05	0.00112	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.49e-05	0.00111	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	2.47e-05	0.0011	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	2.46e-05	0.0011	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.36e-05	0.00105	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	2.32e-05	0.00104	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.31e-05	0.00103	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.27e-05	0.00101	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.25e-05	0.001	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.23e-05	0.000995	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.19e-05	0.000976	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CA4—Alzheimer's disease	2.1e-05	0.000937	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.1e-05	0.000937	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.05e-05	0.000916	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	1.98e-05	0.000881	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.93e-05	0.000862	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CA4—Alzheimer's disease	1.92e-05	0.000854	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	1.87e-05	0.000835	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.87e-05	0.000835	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.85e-05	0.000825	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.82e-05	0.00081	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	1.8e-05	0.000803	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLD3—Alzheimer's disease	1.79e-05	0.000797	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.79e-05	0.000797	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.77e-05	0.000787	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.72e-05	0.000768	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	1.71e-05	0.000764	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	1.71e-05	0.000761	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.68e-05	0.000746	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.65e-05	0.000735	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.64e-05	0.000733	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.63e-05	0.000726	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.63e-05	0.000726	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.61e-05	0.000718	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.59e-05	0.00071	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.58e-05	0.000702	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.56e-05	0.000696	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.56e-05	0.000694	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.53e-05	0.000681	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.52e-05	0.000676	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.5e-05	0.00067	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.49e-05	0.000663	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.47e-05	0.000653	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.45e-05	0.000647	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.42e-05	0.000635	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.42e-05	0.000633	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.3e-05	0.000579	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.26e-05	0.000563	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.23e-05	0.000547	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ESR1—Alzheimer's disease	1.23e-05	0.000547	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.19e-05	0.00053	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NOTCH1—Alzheimer's disease	1.19e-05	0.000528	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.13e-05	0.000502	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.12e-05	0.000499	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPARG—Alzheimer's disease	1.12e-05	0.000499	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.12e-05	0.000498	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.07e-05	0.000479	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.03e-05	0.000459	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.03e-05	0.000458	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.03e-05	0.000458	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.02e-05	0.000454	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	9.92e-06	0.000442	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MAOB—Alzheimer's disease	9.84e-06	0.000439	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ND1—Alzheimer's disease	9.58e-06	0.000427	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	9.48e-06	0.000422	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	9.44e-06	0.000421	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	9.44e-06	0.000421	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.37e-06	0.000417	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	9.36e-06	0.000417	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	9.36e-06	0.000417	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.28e-06	0.000414	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—A2M—Alzheimer's disease	9.15e-06	0.000408	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.05e-06	0.000403	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	8.98e-06	0.0004	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	8.72e-06	0.000388	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	8.64e-06	0.000385	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.54e-06	0.000381	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.46e-06	0.000377	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—A2M—Alzheimer's disease	8.42e-06	0.000375	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—A2M—Alzheimer's disease	8.34e-06	0.000372	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.16e-06	0.000364	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ACHE—Alzheimer's disease	7.96e-06	0.000355	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	7.87e-06	0.000351	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	7.46e-06	0.000332	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ENO1—Alzheimer's disease	7.46e-06	0.000332	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.44e-06	0.000332	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.32e-06	0.000326	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	7.32e-06	0.000326	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	7.26e-06	0.000323	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.24e-06	0.000323	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	7.18e-06	0.00032	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—BCHE—Alzheimer's disease	6.94e-06	0.000309	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.86e-06	0.000306	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.86e-06	0.000306	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	6.8e-06	0.000303	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	6.8e-06	0.000303	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.67e-06	0.000297	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	6.54e-06	0.000292	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.42e-06	0.000286	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.38e-06	0.000284	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	6.34e-06	0.000283	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.32e-06	0.000282	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.17e-06	0.000275	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.17e-06	0.000275	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.02e-06	0.000268	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	5.97e-06	0.000266	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.92e-06	0.000264	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.85e-06	0.000261	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.83e-06	0.00026	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	5.78e-06	0.000258	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.7e-06	0.000254	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.5e-06	0.000245	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	5.47e-06	0.000244	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	5.44e-06	0.000243	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.03e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.01e-06	0.000223	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	4.98e-06	0.000222	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LPL—Alzheimer's disease	4.98e-06	0.000222	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	4.96e-06	0.000221	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.79e-06	0.000213	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.73e-06	0.000211	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.58e-06	0.000204	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.54e-06	0.000202	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.49e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.49e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.48e-06	0.0002	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—Alzheimer's disease	4.43e-06	0.000197	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.4e-06	0.000196	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.19e-06	0.000187	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.17e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.17e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.13e-06	0.000184	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.12e-06	0.000184	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.09e-06	0.000182	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.94e-06	0.000175	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.85e-06	0.000172	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.84e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.82e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.81e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.8e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.8e-06	0.000169	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.77e-06	0.000168	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARG—Alzheimer's disease	3.63e-06	0.000162	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—INS—Alzheimer's disease	3.56e-06	0.000159	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.34e-06	0.000149	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.31e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.29e-06	0.000147	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—INS—Alzheimer's disease	3.28e-06	0.000146	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.27e-06	0.000146	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—INS—Alzheimer's disease	3.25e-06	0.000145	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.13e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.99e-06	0.000133	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.87e-06	0.000128	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.86e-06	0.000127	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.85e-06	0.000127	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.69e-06	0.00012	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.63e-06	0.000117	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.61e-06	0.000116	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.52e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.51e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.49e-06	0.000111	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.19e-06	9.74e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—INS—Alzheimer's disease	2.14e-06	9.55e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.88e-06	8.38e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.72e-06	7.66e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.44e-06	6.4e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.32e-06	5.89e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.31e-06	5.84e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.64e-07	3.85e-05	CbGpPWpGaD
